COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹95 Cr | ₹102 Cr | ₹65 Cr | ₹58 Cr | ₹54 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of COHANCE LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹95 Cr |
| Mar2025 | ₹102 Cr |
| Mar2024 | ₹65 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹54 Cr |
How is Deferred Tax Assets / Liabilities of COHANCE LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹95 Cr | -6.64 | |
| Mar2025 | ₹102 Cr | 57.49 | |
| Mar2024 | ₹65 Cr | 11.26 | |
| Mar2023 | ₹58 Cr | 7.22 | |
| Mar2022 | ₹54 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,206.9 Cr | -6.2% | -4% | -56.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -6.2% |
-4% |
-56.8% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses